Clinical trial
Phase 3 The Comparative Clinical Study of Gamisoyosan on Anxiety of Generalized Anxiety Disorder According to Dosage Form : A Randomized, Double Blind, Parallel-controlled Trial
NCT01285115 is registered in ClinicalTrials.gov with Korea Health Industry Development Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 3 The Comparative Clinical Study of Gamisoyosan on Anxiety of Generalized Anxiety Disorder According to Dosage Form : A Randomized, Double Blind, Parallel-controlled Trial
- Lead sponsor
- Korea Health Industry Development Institute
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2008
- Completion date
- July 31, 2010
- Enrollment
- 147 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.